Anti-FAM163A antibody produced in rabbit，100UL，HPA010778-100UL，Sigma

General description

FAM163A (family with sequence similarity 163, member A) is a secreted protein, which is also called neuroblastoma-derived secretory protein (NDSP). This gene is located on human chromosome 1q25.2. The encoded protein contains a C-C motif and a signal peptide made of 30 amino acids. It consists of 167 amino acids, and is secreted as both, a monomer and a homodimer. Its molecular weight is 18kDa. It is normally expressed in adrenal gland, brain, thymus, colon, ileum, uterus, and testes, where it has the highest level of expression in testes.

Immunogen

UPF0417 protein C1orf76 recombinant protein epitope signature tag (PrEST)

Application

All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry.

The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. We also provide Prestige Antibodies^® protocols and other useful information.

Biochem/physiol Actions

FAM163A (family with sequence similarity 163, member A) is up-regulated in neuroblastoma, as opposed to normal tissues and adult and pediatric cancers. It therefore, plays a role in tumorigenesis of neuroblastoma. This might be achieved by it acting as a ligand for growth factors receptors. It prevents anoikis and supports anchorage independent growth, via ERK (extracellular signal-regulated kinases)-mediated proliferation pathway. FAM163A can therefore, be used as therapeutic target in neuroblastoma. Its mRNA levels also correlate with the risk level in neuroblastoma, and thus, have potential as a marker to determine the metastasis in bone marrow.

Features and Benefits

Prestige Antibodies^® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies^® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section.

Every Prestige Antibody is tested in the following ways:

• IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues.
• Protein array of 364 human recombinant protein fragments.

Physical form

Solution in phosphate-buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide

Other Notes

Corresponding Antigen APREST72031

Legal Information

Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany